Hormone-sensitive Metastatic Prostate Cancer

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2024-06-25
Clinical Trial Update: Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients
A recruiting clinical trial evaluating whether adding chemotherapy or an androgen receptor–targeting agent (alone or with radiotherapy) to a…